A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+ tumor cells
Reusch, Uwe, Duell, Johannes, Ellwanger, Kristina, Herbrecht, Carmen, Knackmuss, Stefan HJ, Fucek, Ivica, Eser, Markus, McAleese, Fionnuala, Molkenthin, Vera, Le Gall, Fabrice, Topp, Max, Little, Melvyn, Zhukovsky, Eugene A
Published in mAbs (04.05.2015)
Published in mAbs (04.05.2015)
Get full text
Journal Article
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells
Gantke, Thorsten, Weichel, Michael, Herbrecht, Carmen, Reusch, Uwe, Ellwanger, Kristina, Fucek, Ivica, Eser, Markus, Müller, Thomas, Griep, Remko, Molkenthin, Vera, Zhukovsky, Eugene A, Treder, Martin
Published in Protein engineering, design and selection (01.09.2017)
Published in Protein engineering, design and selection (01.09.2017)
Get full text
Journal Article
Abstract 2471: EGFRvIII T-cell TandAbs are specific and highly potent drug candidates for the treatment of a variety of solid tumors
Ellwanger, Kristina, Reusch, Uwe, Fucek, Ivica, Weichel, Michael, Herbrecht, Carmen, Knackmuss, Stefan, Rajkovic, Erich, Molkenthin, Vera, Zhukovsky, Eugene A.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article